R, S., S, M., MS, B., AE, W. H., KH, B., WA, C., . . . A, K. (2026). Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomes. Gynecologic oncology, 211, 9. https://doi.org/10.1016/j.ygyno.2026.06.009
Chicago Style (17th ed.) CitationR, Suleiman, et al. "Prehabilitation During Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Is Associated with Improved Surgical Candidacy and Chemotherapy Outcomes." Gynecologic Oncology 211 (2026): 9. https://doi.org/10.1016/j.ygyno.2026.06.009.
MLA (9th ed.) CitationR, Suleiman, et al. "Prehabilitation During Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Is Associated with Improved Surgical Candidacy and Chemotherapy Outcomes." Gynecologic Oncology, vol. 211, 2026, p. 9, https://doi.org/10.1016/j.ygyno.2026.06.009.